Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation

Stock Information for Diffusion Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RETA, EQRX, DFFN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DFFN, TRTN, CNXC
IMPORTANT ALERT: Halper Sadeh LLC Investigates CFMS, DFFN, ARNC, GRNA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CIR, CTIC, DFFN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, RADI, BGRY, DFFN
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DFFN, CNXC, LSI
Lifshitz Law PLLC Announces Investigations of KYN, KMF, CNXC, and DFFN

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.